Find clinical trials for Lung Cancer in Dallas, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Non-Small-Cell Lung Carcinoma

Small Cell Lung Carcinoma

Cancer

Colorectal Cancer

Neoplasm Metastasis

Breast Cancer

Squamous Cell Carcinoma of Head and Neck

Lung Cancer trials near Dallas, TX, USA:

Efficacy and Safety of a Single Dose of LS301-IT for Fluorescence Intraoperative Molecular Imaging (IMI) for Patients Undergoing Lung Cancer Resection for Non Small Cell Lung Cancer

undergoing VATS (Video-Assisted Thoracoscopic Surgery) or RATS (Robotic-Assisted Thoracoscopic Surgery) resection of Stage I-II non-small cell lung...

Enrolling

Non Small Cell Lung Cancer (NSCLC)

Drug: LS301-IT 0.1 mg/kg

Phase 2

Integro Theranostics

Dallas, Texas, United States and 1 other location

Study of DS-1062a Versus Docetaxel in Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer With or Without Actionable Genomic Alterations (TROPION-LUNG01)

with previously treated advanced or metastatic non-small cell lung cancer (NSCLC) with or without actionable genomic alterations....

Active, not recruiting

Non-small Cell Lung Cancer

Drug: Docetaxel

Drug: DS-1062a

Phase 3

Daiichi Sankyo

Fort Worth, Texas, United States and 210 other locations

Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer

given with chemotherapy to adults with extensive-stage small cell lung cancer (ES-SCLC), a fast-growing type of lung cancer...

Enrolling

Small Cell Lung Cancer (SCLC)

Drug: Chemotherapy

Drug: PF-08634404

Phase 2, Phase 3

Pfizer

Dallas, Texas, United States and 81 other locations

BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)

combination) vs durvalumab in limited-stage (LS)-small-cell lung cancer (SCLC) participants.The main goals of this study are to:* E...

Active, not recruiting

Limited Stage Small Cell Lung Cancer

Drug: Durvalumab

Drug: BMS-986489

Phase 2

SCRI Development Innovations

Dallas, Texas, United States and 33 other locations

A Study to Learn About the Study Medicine Called Ponsegromab in Adults With Lung Cancer-Associated Significant Body Weight Loss

Study to investigate the effect of ponsegromab on skeletal muscle mass and physical function in adult participants with non-small cell lung ...

Begins enrollment this month

Non-small Cell Lung Cancer (NSCLC)

Cachexia

Drug: ponsegromab

Drug: placebo

Phase 1

Pfizer

Garland, Texas, United States and 6 other locations

Feasibility Study of Personalized Ultra-fractionated Stereotactic Ablative Radiotherapy (PULSAR) for Cancers of the Central Lung

The objective of this study is to enhance the safety profile of SAbR in ultra-central tumors of the lung (primary or metastatic) without com...

Enrolling

Cancer, Lung

Metastasis

Radiation: Personalized Ultra-fractionated stereotactic ablative radiotherapy (PULSAR)

Early Phase 1

The University of Texas System (UT)

Dallas, Texas, United States

A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer

with advanced/metastatic or relapsed/progressive small cell lung cancer (SCLC) and non small cell lung cancer (NS...

Enrolling

Advanced Lung Cancer

Biological: BNT327

Biological: BNT324

Phase 1, Phase 2

BioNTech

Dallas, Texas, United States and 90 other locations

A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer

This is Phase 1/2, multicenter, clinical study to evaluate the safety, efficacy, PK, and immunogenicity of IDE849 in subjects with DLL3-expressing tu...

Enrolling

Small-cell Lung Cancer

Neuroendocrine Carcinomas

Drug: durvalumab

Drug: IDE849

Phase 1, Phase 2

Ideaya Biosciences

Irving, Texas, United States and 14 other locations

Study of Durvalumab + Tremelimumab, Durvalumab, and Placebo in Limited Stage Small-Cell Lung Cancer in Patients Who Have Not Progressed Following Concurrent Chemoradiation Therapy (ADRIATIC)

This is a Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center, International Study of Durvalumab or Durvalumab and Tremelimumab as...

Active, not recruiting

Small Cell Lung Cancer

Drug: Durvalumab

Other: Placebo

Phase 3

AstraZeneca

Dallas, Texas, United States and 182 other locations

A Study Evaluating the Efficacy and Safety of Divarasib Versus Sotorasib or Adagrasib in Participants With Previously Treated KRAS G12C-positive Advanced or Metastatic Non-Small Cell Lung Cancer (Krascendo 1)

KRAS G12C inhibitors (sotorasib or adagrasib) in participants with KRAS G12C-positive (KRAS G12C +) advanced or metastatic non-small cell lung...

Active, not recruiting

KRAS G12C Lung Cancer

Non-Small Cell Lung Cancer

Drug: Sotorasib

Drug: Divarasib

Phase 3

Roche

Fort Worth, Texas, United States of America and 156 other locations

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms

Find clinical trials for Lung Cancer in .css-epvm6{white-space:nowrap;}Dallas, TX

Related conditions:

Lung Cancer trials near Dallas, TX, USA:

Efficacy and Safety of a Single Dose of LS301-IT for Fluorescence Intraoperative Molecular Imaging (IMI) for Patients Undergoing Lung Cancer Resection for Non Small Cell Lung Cancer

Study of DS-1062a Versus Docetaxel in Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer With or Without Actionable Genomic Alterations (TROPION-LUNG01)

Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer

BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)

A Study to Learn About the Study Medicine Called Ponsegromab in Adults With Lung Cancer-Associated Significant Body Weight Loss

Feasibility Study of Personalized Ultra-fractionated Stereotactic Ablative Radiotherapy (PULSAR) for Cancers of the Central Lung

A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer

A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer

Study of Durvalumab + Tremelimumab, Durvalumab, and Placebo in Limited Stage Small-Cell Lung Cancer in Patients Who Have Not Progressed Following Concurrent Chemoradiation Therapy (ADRIATIC)

A Study Evaluating the Efficacy and Safety of Divarasib Versus Sotorasib or Adagrasib in Participants With Previously Treated KRAS G12C-positive Advanced or Metastatic Non-Small Cell Lung Cancer (Krascendo 1)

Find clinical trials for Lung Cancer in Dallas, TX